AiArthritis Launches #WTHellth?! to Support Patients Frustrated with the Health Care System and Amplify their Voices 

October 1st, 2025 - (St. Louis, Missouri) – Today, the International Foundation for Autoimmune & Autoinflammatory Arthritis (AiArthritis) launched #WTHellth?!, a social media focused campaign amplifying real people’s stories about the often-hellish world of health care. From long wait times and high medical bills to concerns about insurance abruptly or inappropriately switching medications, #WTHellth?! is a way for frustrated patients to share their experiences - and take action as a community.


“As someone living with non-radiographic axial spondyloarthritis, I know how scary it can be to navigate a system that, at the end of the day, seems to prioritize profit margins over real people. That’s why patients are at the center of everything we do,” said Tiffany Westrich-Robertson, CEO of AiArthritis. “No one knows better than a patient who is personally impacted. Through #WTHellth?!, we’re working together to amplify patient perspectives, find solutions, and fight for the care we deserve.”

The name #WTHellth?! riffs on the widely used online abbreviation “WTH” to illustrate the “hellish” experiences people face when navigating our health care system. These rants are not limited to patients living with autoimmune or autoinflammatory arthritis. #WTHellth?! is a disease-agnostic campaign encouraging submissions from any person who has faced challenges within the health care system – whether it’s difficulties dealing with health insurers, hospitals, pharmacy benefit managers, or other barriers to accessing treatments.


#WTHellth?! contributors submit a variety of content – some use humor, memes, and trending soundbites to demonstrate what they went through, while others soulfully recount their plight from start to finish. One patient shared a story about how insurance initially denied her the rheumatology medication she needed, only to be eligible for it a year later. Once she was eligible, it drastically improved her life, but there never should have been a yearlong delay for her to find relief. ”


One of the most exhausting and frustrating things to do as a patient is self-advocacy, but it can also be incredibly empowering,” said Leila P.L. Valete, Health Education Manager at AiArthritis and #WTHellth?! contributor. “Venting through #WTHellth?! about the time I was automatically switched to a cheaper medication that did nothing for my lupus really helped me connect with people who were going through the same thing. Sharing your story can help you stand up for yourself and let others in the same situation know they’re not alone.”


Examples of #WTHellth?! videos, social media pages and detailed submission information can be found on the website.


Participating is easy: Either post your own video on any social media platform and add the tag #WTHellth?! Or simply visit the website and submit your story through the online form, where there is an option to remain anonymous.


Download Press Release

About AiArthritis

The International Foundation for Autoimmune & Autoinflammatory Arthritis (AiArthritis) was founded in 2011 by people living with autoimmune and autoinflammatory arthritis diseases. Over the past decade, AiArthritis has emerged as a leader in education, public policy, and research, serving on advisory panels, participating as research liaisons, and using patient experience data to influence policy. Learn more via aiarthritis.org. 


Discover The #WTHellth?! Video Library

IV drip bag hanging on a stand in a softly lit hospital room

Early Treatment for Rheumatoid Arthritis: What the Debate Really Means for Patients

May 30, 2026
Explore the latest discussion on early treatment for rheumatoid arthritis and what current research reveals about diagnosis, intervention, and long-term patient outcomes.
Woman in a white blazer seated at a vanity, holding a makeup mirror in a softly lit room.

What New Research Is Teaching Us About RA Risk, Early Treatment, and Lung Disease

May 30, 2026
Discover the latest research on rheumatoid arthritis, including insights into disease risk, the importance of early treatment, and the connection between RA and lung disease.
Person seated on a chair, clutching a glowing red knee in pain

Difficult-to-Treat and Poly-Refractory Rheumatoid Arthritis: What New Research Is Teaching Us

May 29, 2026
Explore what emerging research is teaching us about difficult-to-treat and poly-refractory rheumatoid arthritis, including the challenges patients face when treatments stop working and the search for more personalized approaches to care.
Older man using a tablet at a desk in a bright home office

Understanding VEXAS Syndrome: Why This Newly Identified Condition Matters for AiArthritis Disease Patients

May 29, 2026
Learn about VEXAS syndrome, a newly identified inflammatory condition linked to immune system dysfunction, and why greater awareness may help patients with complex or overlapping AiArthritis disease symptoms find answers sooner.
More Posts